Pharmaceutical Benefits Scheme Insulin Pump

The Australian Government provides a subsidy to help young people with type 1 diabetes to move from multiple daily insulin injection to insulin pump therapy.

Insulin pumps assist with keeping glucose at more stable l levels and assist in the reduction of complications for young people with type 1 diabetes.

Insulin pump therapy improves the quality of life of people living with type 1 diabetes An insulin pump significantly improves the health of users by making it easier to control their condition. It also reduces the need for parents to supervise the management of diabetes in children.

The program will provide means-tested subsidies of $500 to $2,500 for young people to purchase an insulin pump.

The Juvenile Diabetes Research Foundation (JDRF) will administer the program for the Government. JDRF will provide the point-of-contact for young people and their families who are seeking financial assistance with the purchase cost of an insulin pump.

This announcement builds on the $400 million each year in Australian Government support for diabetic products supplied through the National Diabetes Services Scheme and expenditure on medicines for diabetes through the Pharmaceutical Benefits Scheme.

Around 2000 new cases of type 1 diabetes are diagnosed in Australia each year, including 1000 young people under the age of 18.